Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases
- PMID: 31312902
- PMCID: PMC8583383
- DOI: 10.1007/s00270-019-02284-9
Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases
Abstract
role of liver-directed chemotherapy and loco-regional interventions in managing colorectal cancer liver metastases
Conflict of interest statement
Conflict of interest (COI)
Authors Jia Li, Ieva Kurilova, Juan C Camacho declare that they have no conflict of interest.
Nancy Kemeny received research fund from Amgen
Constantinos T. Sofocleous declare Research Support: Ethicon J&J, BTG, Consultant/Advisory Board: Terumo, Ethicon J&J, GE.
References
-
- National Cancer Institute Surveillance Epidemiology and End Results Program. Cancer Stat Facts: Colon and Rectum Cancer https://seer.cancer.gov/statfacts/html/colorect.html. Accessed May 17, 2018.
-
- Siegel RL, Miller KD, and Jemal A, Cancer statistics, 2018. CA Cancer J Clin, 2018. 68(1): p. 7–30. - PubMed
-
- Ghiringhelli F, et al., Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based study. Dig Liver Dis, 2014. 46(9): p. 854–8. - PubMed
-
- Lee MS, Menter DG, and Kopetz S, Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes. J Natl Compr Canc Netw, 2017. 15(3): p. 411–419. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
